Skip to main content
Log in

Is IPC a cost-effective option in malignant pleural effusion?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. EuroQol Group five-dimensional three-level questionnaire

Reference

  • Olfert JA, et al. Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion. Respirology : 16 Dec 2016. Available from: URL: http://doi.org/10.1111/resp.12962

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Is IPC a cost-effective option in malignant pleural effusion?. PharmacoEcon Outcomes News 769, 17 (2017). https://doi.org/10.1007/s40274-017-3653-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3653-0

Navigation